Michael J. Pishvaian, Takayuki Yoshino, Colin D. Weekes, Makoto Ueno, Richard S. Finn, Naimin Jing, Ken Hatogai, David E. Adelberg, Do-Youn Oh. "Phase 1/2 study of the trophoblast cell surface antigen 2 (TROP2) antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) as monotherapy or combination therapy in gastrointestinal cancers: LIGHTBEAM-02A.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.tps846